XML 65 R16.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2014

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill And Intangible Assets Disclosure [Text Block]

Note 10 – Goodwill and Other Intangible Assets

The changes in carrying amount of goodwill for the six months ended June 30, 2014 are as follows and the Company has recorded no impairment charges in the past:

		North						South
		America		EMEA		Asia/Pacific		America		Total
Balance as of December 31, 2013		$	28,127	$	11,184	$	15,018	$	3,822	$	58,151
	Currency translation adjustments		308		172		231		59		770
Balance as of June 30, 2014		$	28,435	$	11,356	$	15,249	$	3,881	$	58,921

Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of June 30, 2014 and December 31, 2013 are as follows:

		Gross Carrying				Accumulated
		Amount				Amortization
Definite-lived intangible assets		2014		2013		2014		2013
	Customer lists and rights to sell	$	33,607	$	33,559	$	11,234	$	10,221
	Trademarks and patents		6,830		6,838		3,532		3,202
	Formulations and product technology		5,808		5,808		3,802		3,709
	Other		5,543		5,544		4,663		4,445
	Total	$	51,788	$	51,749	$	23,231	$	21,577

The Company recorded $1,628 and $1,763 of amortization expense in the six months ended June 30, 2014 and June 30, 2013, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:

For the year ended December 31, 2014	$	3,257
For the year ended December 31, 2015	$	3,257
For the year ended December 31, 2016	$	2,781
For the year ended December 31, 2017	$	2,121
For the year ended December 31, 2018	$	2,097
For the year ended December 31, 2019	$	2,097

The Company has two indefinite-lived intangible assets totaling $1,100 for trademarks at June 30, 2014.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details